Viridian Therapeutics Inc
NASDAQ:VRDN

Watchlist Manager
Viridian Therapeutics Inc Logo
Viridian Therapeutics Inc
NASDAQ:VRDN
Watchlist
Price: 22.43 USD -12.76% Market Closed
Market Cap: 1.7B USD
Have any thoughts about
Viridian Therapeutics Inc?
Write Note

Viridian Therapeutics Inc
Other Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Viridian Therapeutics Inc
Other Equity Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Other Equity Analysis
Latest Figures & CAGR of Competitors

Company Other Equity CAGR 3Y CAGR 5Y CAGR 10Y
Viridian Therapeutics Inc
NASDAQ:VRDN
Other Equity
-$543k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Other Equity
-$2.3B
CAGR 3-Years
10%
CAGR 5-Years
2%
CAGR 10-Years
-10%
Gilead Sciences Inc
NASDAQ:GILD
Other Equity
$18.4B
CAGR 3-Years
526%
CAGR 5-Years
175%
CAGR 10-Years
61%
Amgen Inc
NASDAQ:AMGN
Other Equity
-$336m
CAGR 3-Years
25%
CAGR 5-Years
6%
CAGR 10-Years
-12%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Other Equity
$15.6B
CAGR 3-Years
992%
CAGR 5-Years
287%
CAGR 10-Years
163%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Other Equity
$60.2m
CAGR 3-Years
82%
CAGR 5-Years
29%
CAGR 10-Years
8%

See Also

What is Viridian Therapeutics Inc's Other Equity?
Other Equity
-543k USD

Based on the financial report for Jun 30, 2024, Viridian Therapeutics Inc's Other Equity amounts to -543k USD.

What is Viridian Therapeutics Inc's Other Equity growth rate?
Other Equity CAGR 1Y
-172%

Over the last year, the Other Equity growth was -172%.

Back to Top